{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:27:57Z","timestamp":1791401277344,"version":"4.3.3"},"reference-count":64,"publisher":"Impact Journals, LLC","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,5,24]]},"DOI":"10.18632\/oncotarget.9093","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T06:20:29Z","timestamp":1461910829000},"page":"29901-29915","source":"Crossref","is-referenced-by-count":59,"title":["Collecting duct carcinoma of the kidney is associated with<i>CDKN2A<\/i>deletion and<i>SLC<\/i>family gene up-regulation"],"prefix":"10.18632","volume":"7","author":[{"given":"Jianmin","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Biostatistics & Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios","family":"Papanicolau-Sengos","sequence":"additional","affiliation":[{"name":"Department of Pathology and Center for Personalized Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreenivasulu","family":"Chintala","sequence":"additional","affiliation":[{"name":"Genitourinary Program, Roswell Park Cancer Institute, Buffalo, NY, USA"},{"name":"Genitourinary Program, Indiana University-Simon Cancer Center, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Biostatistics & Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Biostatistics & Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Biostatistics & Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiersten Marie","family":"Miles","sequence":"additional","affiliation":[{"name":"Department of Pathology and Center for Personalized Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Conroy","sequence":"additional","affiliation":[{"name":"Department of Pathology and Center for Personalized Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean T.","family":"Glenn","sequence":"additional","affiliation":[{"name":"Cancer Genetics, Roswell Park Cancer Institute, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Costantini","sequence":"additional","affiliation":[{"name":"Department of Urology, Regina Elena National Cancer Institute of Rome, Rome, Italy"},{"name":"Laboratory of Genetic and Clinical Pathology, University Campus BioMedico of Rome, Rome, Italy"},{"name":"Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Magi-Galluzzi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Signoretti","sequence":"additional","affiliation":[{"name":"Department of Pathology and Kidney Cancer Program, Dana Farber, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Choueiri","sequence":"additional","affiliation":[{"name":"Department of Pathology and Kidney Cancer Program, Dana Farber, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Gallucci","sequence":"additional","affiliation":[{"name":"Department of Urology, Regina Elena National Cancer Institute of Rome, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steno","family":"Sentinelli","sequence":"additional","affiliation":[{"name":"Department of Urology, Regina Elena National Cancer Institute of Rome, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito M.","family":"Fazio","sequence":"additional","affiliation":[{"name":"Laboratory of Genetic and Clinical Pathology, University Campus BioMedico of Rome, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luana","family":"Poeta","sequence":"additional","affiliation":[{"name":"Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Biostatistics & Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Morrison","sequence":"additional","affiliation":[{"name":"Department of Pathology and Center for Personalized Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pili","sequence":"additional","affiliation":[{"name":"Genitourinary Program, Roswell Park Cancer Institute, Buffalo, NY, USA"},{"name":"Genitourinary Program, Indiana University-Simon Cancer Center, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,4,28]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"E589","DOI":"10.5489\/cuaj.2932","article-title":"Collecting (Bellini) duct carcinoma: A clinical study of a rare tumour and review of the literature","volume":"9","author":"Smolska-Ciszewska","year":"2015","journal-title":"Can Urol Assoc J"},{"key":"2","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/PAS.0b013e3182635954","article-title":"Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma: clinicopathologic analysis of 52 cases of rare aggressive subtypes of renal cell carcinoma with a focus on their interrelationship","volume":"36","author":"Amin","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"Suppl 2","key":"3","first-page":"S2","article-title":"Uncommon and recently described renal carcinomas","volume":"22","author":"Delahunt","year":"2009","journal-title":"Mod Pathol"},{"key":"4","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.3747\/co.20.1230","article-title":"Management of renal collecting duct carcinoma: a systematic review and the McMaster experience","volume":"20","author":"Kapoor","year":"2013","journal-title":"Curr Oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0022-5347(06)00502-7","article-title":"Collecting duct (Bellini duct) renal cell carcinoma: a nationwide survey in Japan","volume":"176","author":"Japanese Society of Renal","year":"2006","journal-title":"The Journal of urology"},{"key":"6","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1016\/j.juro.2009.08.049","article-title":"Effect of collecting duct histology on renal cell cancer outcome","volume":"182","author":"Lin","year":"2009","journal-title":"The Journal of urology"},{"key":"7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4143\/crt.2014.46.2.141","article-title":"Clinical features and treatment of collecting duct carcinoma of the kidney from the korean cancer study group genitourinary and gynecology cancer committee","volume":"46","author":"Rha","year":"2014","journal-title":"Cancer research and treatment"},{"key":"8","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.juro.2013.02.035","article-title":"Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk model","volume":"190","author":"Longo","year":"2013","journal-title":"The Journal of urology"},{"key":"9","first-page":"1027","article-title":"Treatment of collecting duct carcinoma: current status and future perspectives","volume":"34","author":"De Braud","year":"2014","journal-title":"Anticancer research"},{"key":"10","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.eururo.2012.06.043","article-title":"A phase 2 trial of sunitinib in patients with advanced non-clear cell renal cell carcinoma","volume":"62","author":"Jonasch","year":"2012","journal-title":"European urology"},{"key":"11","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s11255-013-0468-1","article-title":"Active targeted therapy for metastatic collecting duct carcinoma of the kidney: a case report and review of the literature","volume":"45","author":"Wei","year":"2013","journal-title":"International urology and nephrology"},{"key":"12","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1111\/j.1464-410X.2008.08290.x","article-title":"Genetic alterations and chemosensitivity profile in newly established human renal collecting duct carcinoma cell lines","volume":"103","author":"Kim","year":"2009","journal-title":"BJU international"},{"key":"13","article-title":"Characterization of Clinical Cases of Collecting Duct Carcinoma of the Kidney Assessed by Comprehensive Genomic Profiling","author":"Lin","year":"2015","journal-title":"European urology"},{"key":"14","doi-asserted-by":"crossref","first-page":"e78137","DOI":"10.1371\/journal.pone.0078137","article-title":"Collecting duct carcinomas represent a unique tumor entity based on genetic alterations","volume":"8","author":"Jung","year":"2013","journal-title":"PLoS One"},{"key":"15","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/bioinformatics\/btr032","article-title":"Bambino: a variant detector and alignment viewer for next-generation sequencing data in the SAM\/BAM format","volume":"27","author":"Buetow","year":"2011","journal-title":"Bioinformatics"},{"key":"16","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Durbin","year":"2009","journal-title":"Bioinformatics"},{"key":"17","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Hakonarson","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"18","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nature08672","article-title":"Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes","volume":"463","author":"Campbell","year":"2010","journal-title":"Nature"},{"key":"19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nature09639","article-title":"Exome sequencing identifies frequent mutation of the SWI\/SNF complex gene PBRM1 in renal carcinoma","volume":"469","author":"Greenman","year":"2011","journal-title":"Nature"},{"key":"20","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1158\/1541-7786.MCR-13-0111","article-title":"A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma","volume":"11","author":"Xie","year":"2013","journal-title":"Molecular cancer research"},{"key":"21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1535-6108(02)00102-2","article-title":"The RB and p53 pathways in cancer","volume":"2","author":"McCormick","year":"2002","journal-title":"Cancer cell"},{"key":"22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35042675","article-title":"Surfing the p53 network","volume":"408","author":"Levine","year":"2000","journal-title":"Nature"},{"key":"23","first-page":"39","article-title":"Epigenetic Mechanisms Leading to Overexpression of HMGA Proteins in Human Pituitary Adenomas","volume":"2","author":"Fusco","year":"2015","journal-title":"Front Med (Lausanne)"},{"key":"24","doi-asserted-by":"publisher","first-page":"9410","DOI":"10.18632\/oncotarget.2421","article-title":"Overexpression of collagen triple helix repeat containing 1 (CTHRC1) is associated with tumour aggressiveness and poor prognosis in human non-small cell lung cancer","volume":"5","author":"Wang","year":"2014","journal-title":"Oncotarget"},{"key":"25","doi-asserted-by":"crossref","first-page":"10825","DOI":"10.3748\/wjg.v20.i31.10825","article-title":"Novel therapeutic targets for pancreatic cancer","volume":"20","author":"Chen","year":"2014","journal-title":"World J Gastroenterol"},{"key":"26","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00109-013-1055-8","article-title":"HMGA2 and high-grade serous ovarian carcinoma","volume":"91","author":"Wei","year":"2013","journal-title":"J Mol Med (Berl)"},{"key":"27","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1038\/srep05251","article-title":"Expression of human solute carrier family transporters in skin: possible contributor to drug-induced skin disorders","volume":"4","author":"Itoh","year":"2014","journal-title":"Scientific reports"},{"key":"28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrd4626","article-title":"SLC transporters as therapeutic targets: emerging opportunities","volume":"14","author":"Giacomini","year":"2015","journal-title":"Nature reviews Drug discovery"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.5772\/55139","article-title":"MiRNA and Proline Metabolism in Cancer, Oncogene and Cancer - From Bench to Clinic","author":"Siregar","year":"2013","journal-title":"InTech"},{"key":"30","doi-asserted-by":"crossref","first-page":"e92028","DOI":"10.1371\/journal.pone.0092028","article-title":"Proline modulates the Trypanosoma cruzi resistance to reactive oxygen species and drugs through a novel D, L-proline transporter","volume":"9","author":"Pereira","year":"2014","journal-title":"PLoS One"},{"key":"31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.mam.2013.01.001","article-title":"The SLC1 high-affinity glutamate and neutral amino acid transporter family","volume":"34","author":"Hediger","year":"2013","journal-title":"Mol Aspects Med"},{"key":"32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1186\/s12885-015-1405-8","article-title":"The glutamate transport inhibitor DL-Threo-beta-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cells","volume":"15","author":"Pedersen","year":"2015","journal-title":"BMC Cancer"},{"key":"33","first-page":"120","article-title":"xCT, not just an amino-acid transporter: a multi-functional regulator of microbial infection and associated diseases","volume":"6","author":"Qin","year":"2015","journal-title":"Front Microbiol"},{"key":"34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1586\/era.11.201","article-title":"Molecular mechanisms of cisplatin resistance in bladder cancer","volume":"12","author":"Catto","year":"2012","journal-title":"Expert Rev Anticancer Ther"},{"key":"35","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1158\/1078-0432.CCR-13-2805","article-title":"Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine\/glutamate exchanger SLC7A11","volume":"20","author":"Catto","year":"2014","journal-title":"Clinical cancer research"},{"key":"36","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1089\/ars.2011.4391","article-title":"The cystine\/glutamate antiporter system x(c)(\u2212) in health and disease: from molecular mechanisms to novel therapeutic opportunities","volume":"18","author":"Maher","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"37","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.biopha.2012.11.011","article-title":"Microarray-based detection and expression analysis of ABC and SLC transporters in drug-resistant ovarian cancer cell lines","volume":"67","author":"Zabel","year":"2013","journal-title":"Biomedicine & pharmacotherapy"},{"key":"38","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000316334","article-title":"Downregulation of cystine transporter xc by irinotecan in human head and neck cancer FaDu xenografts","volume":"56","author":"Rustum","year":"2010","journal-title":"Chemotherapy"},{"key":"39","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00280-008-0894-4","article-title":"The xc- cystine\/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine","volume":"64","author":"Wang","year":"2009","journal-title":"Cancer chemotherapy and pharmacology"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Lu, Samanta, Xiang, Zhang, Hu, Chen, Bullen, Semenza. Chemotherapy triggers HIF-1-dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype. Proceedings of the National Academy of Sciences of the United States of America. 2015. 112:pp. E4600\u20134609.","DOI":"10.1073\/pnas.1513433112"},{"key":"41","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccr.2013.08.020","article-title":"Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target","volume":"24","author":"Gray","year":"2013","journal-title":"Cancer cell"},{"key":"42","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1128\/MCB.00221-14","article-title":"Nrf2- and ATF4-dependent upregulation of xCT modulates the sensitivity of T24 bladder carcinoma cells to proteasome inhibition","volume":"34","author":"Itoh","year":"2014","journal-title":"Mol Cell Biol"},{"key":"43","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1158\/0008-5472.CAN-12-3609-T","article-title":"xCT inhibition depletes CD44v-expressing tumor cells that are resistant to EGFR-targeted therapy in head and neck squamous cell carcinoma","volume":"73","author":"Nagano","year":"2013","journal-title":"Cancer research"},{"key":"44","first-page":"47","article-title":"Theanine and glutamate transporter inhibitors enhance the antitumor efficacy of chemotherapeutic agents","volume":"1653","author":"Sadzuka","year":"2003","journal-title":"Biochimica et biophysica acta"},{"key":"45","doi-asserted-by":"crossref","first-page":"8380","DOI":"10.1038\/srep08380","article-title":"Inhibitors of glutamate release from breast cancer cells; new targets for cancer-induced bone-pain","volume":"5","author":"Singh","year":"2015","journal-title":"Scientific reports"},{"key":"46","first-page":"lb452","article-title":"Colorectal cancer cell lines made resistant to SN38-and Oxaliplatin: Roles of altered ion transporter function in resistance?","volume":"27","author":"Stenvang","year":"2013","journal-title":"The FASEB Journal"},{"key":"47","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16982","article-title":"Tumour-specific proline vulnerability uncovered by differential ribosome codon reading","volume":"530","author":"Agami","year":"2016","journal-title":"Nature"},{"key":"48","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Schultz","year":"2012","journal-title":"Cancer Discov"},{"key":"49","first-page":"pl1","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Schultz","year":"2013","journal-title":"Sci Signal"},{"key":"50","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1093\/annonc\/mdt423","article-title":"Triple combination of bevacizumab, gemcitabine and platinum salt in metastatic collecting duct carcinoma","volume":"24","author":"Oudard","year":"2013","journal-title":"Annals of oncology"},{"key":"51","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1159\/000345041","article-title":"HER2 blockade in metastatic collecting duct carcinoma (CDC) of the kidney: a case report","volume":"35","author":"Andreu","year":"2012","journal-title":"Onkologie"},{"key":"52","first-page":"792","article-title":"Bellini renal cell carcinoma : diagnosis and treatment. A report of 7 cases [Article in French]","volume":"89","author":"Horchani","year":"2011","journal-title":"La Tunisie medicale"},{"key":"53","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1477-7819-9-73","article-title":"Metastatic collecting duct carcinoma of the kidney treated with sunitinib","volume":"9","author":"Errihani","year":"2011","journal-title":"World journal of surgical oncology"},{"key":"54","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.canlet.2015.07.031","article-title":"Xc- inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism","volume":"368","author":"Huang","year":"2015","journal-title":"Cancer letters"},{"key":"55","first-page":"0","article-title":"Decreased MicroRNA-26a expression causes cisplatin resistance in human non-small cell lung cancer","author":"Fan","year":"2015","journal-title":"Cancer biology & therapy"},{"key":"56","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1158\/0008-5472.CAN-10-1855","article-title":"Three-dimensional collagen I promotes gemcitabine resistance in pancreatic cancer through MT1-MMP-mediated expression of HMGA2","volume":"71","author":"Munshi","year":"2011","journal-title":"Cancer research"},{"key":"57","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jhep.2010.11.011","article-title":"Epithelial-to-mesenchymal transition and acquired resistance to sunitinib in a patient with hepatocellular carcinoma","volume":"54","author":"Faivre","year":"2011","journal-title":"Journal of hepatology"},{"key":"58","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/carcin\/bgs378","article-title":"Collagen triple helix repeat containing-1 promotes pancreatic cancer progression by regulating migration and adhesion of tumor cells","volume":"34","author":"Koh","year":"2013","journal-title":"Carcinogenesis"},{"key":"59","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1158\/1078-0432.CCR-06-0030","article-title":"Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers","volume":"12","author":"Zhou","year":"2006","journal-title":"Clinical cancer research"},{"key":"60","doi-asserted-by":"crossref","first-page":"R92","DOI":"10.1186\/gb-2010-11-9-r92","article-title":"A statistical approach for detecting genomic aberrations in heterogeneous tumor samples from single nucleotide polymorphism genotyping data","volume":"11","author":"Holmes","year":"2010","journal-title":"Genome biology"},{"key":"61","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq\u2014a Python framework to work with high-throughput sequencing data","volume":"31","author":"Huber","year":"2015","journal-title":"Bioinformatics"},{"key":"62","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Anders","year":"2014","journal-title":"Genome biology"},{"key":"63","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1038\/srep06347","article-title":"GSAASeqSP: a toolset for gene set association analysis of RNA-Seq data","volume":"4","author":"Furey","year":"2014","journal-title":"Scientific reports"},{"key":"64","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1038\/onc.2015.219","article-title":"YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage","volume":"35","author":"Barrera","year":"2016","journal-title":"Oncogene"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9093","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T20:40:02Z","timestamp":1692304802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,28]]},"references-count":64,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2016,5,24]]}},"alternative-id":["9093","27144525"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.9093","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,28]]}}}